N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141411 |
| CAS No | NA |
| Mol.F. | C10H13ClN2O : HCl |
| Mol.Wt. | 212.7 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141412 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141413 |
| CAS No | 500545-48-2 |
| Mol.F. | C15H26ClN3O2 |
| Mol.Wt. | 315.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141414 |
| CAS No | NA |
| Mol.F. | C3H9N3O3S |
| Mol.Wt. | 167.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141415 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141416 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141417 |
| CAS No | NA |
| Mol.F. | C14H20N4O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141418 |
| CAS No | NA |
| Mol.F. | C25H28Cl2N6O5 |
| Mol.Wt. | 563.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141419 |
| CAS No | NA |
| Mol.F. | C26H30Cl2N6O5 |
| Mol.Wt. | 577.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141420 |
| CAS No | NA |
| Mol.F. | C25H26Cl2N6O4 |
| Mol.Wt. | 545.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141421 |
| CAS No | NA |
| Mol.F. | C21H18Cl2N4O4 |
| Mol.Wt. | 461.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141422 |
| CAS No | NA |
| Mol.F. | C34H26N4O6 |
| Mol.Wt. | 586.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141424 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141425 |
| CAS No | NA |
| Mol.F. | C18H17N5O |
| Mol.Wt. | 319.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141423 |
| CAS No | NA |
| Mol.F. | C13H17N3O5 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141426 |
| CAS No | NA |
| Mol.F. | C32H27N5O3 |
| Mol.Wt. | 529.6 |
| INV STATUS | CUSTOM SYNTHESIS |